Clinical Trials Browser

Phase 1/2 × Recruiting × Lymphoma, T-Cell, Peripheral × Clear all

NCT04390737 2026-01-30

Evaluate the Safety and Clinical Activity of HH2853

Phase 1/2 Recruiting

LymphoidSarcoma

Lymphoma, Follicular, Sarcoma, Lymphoma, T-Cell, Peripheral

NCT06909877 2026-01-30

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

Phase 1/2 Recruiting

Recurrence, Lymphoma, T-Cell, Peripheral

NCT07093710 2025-12-31

Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT04068597 2025-12-18

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms

NCT06035497 2025-05-14

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, Mycosis Fungoides, Recurrence, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT06855823 2025-03-04

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

Phase 1/2 Recruiting

Recurrence, Lymphoma, T-Cell, Peripheral

NCT06739265 2024-12-18

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT05934513 2024-12-13

A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Phase 1/2 Recruiting

Recurrence, Lymphoma, T-Cell, Peripheral

NCT05949944 2024-05-17

Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT06173999 2024-05-14

A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT05675813 2024-01-08

THEORY

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral